Comparison of  18 FDG PET/PET-CT and bone scintigraphy for detecting bone metastases in patients with nasopharyngeal cancer: a meta-analysis

Chuanhui Xu; Ruiming Zhang; Huanlei Zhang; Zhenyan Zhang

doi:10.18632/oncotarget.20026

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

Comparison of ¹⁸FDG PET/PET-CT and bone scintigraphy for detecting bone metastases in patients with nasopharyngeal cancer: a meta-analysis

Chuanhui Xu, Ruiming Zhang _, Huanlei Zhang and Zhenyan Zhang

PDF | HTML | How to cite

Oncotarget. 2017; 8:59740-59747. https://doi.org/10.18632/oncotarget.20026

Metrics: PDF 1575 views | HTML 2240 views | ?

Abstract

Chuanhui Xu1,*, Ruiming Zhang1,*, Huanlei Zhang1 and Zhenyan Zhang1

1Department of Radiology, Yidu Central Hospital of Weifang, Qingzhou 262500, Shandong, PR China

*These authors contributed equally to this work as first author

Correspondence to:

Ruiming Zhang, email: [email protected]

Keywords: PET, bone scintigraphy, nasopharyngeal cancer, staging, bone metastases

Received: July 04, 2017 Accepted: July 26, 2017 Published: August 07, 2017

ABSTRACT

Objective: We performed a meta-analysis to compare the diagnostic efficacy of ¹⁸FDG PET/PET-CT and bone scintigraphy (BS) for diagnosing bone metastatic cancers in nasopharyngeal cancer patients.

Results: 6 studies (1238 patients) fulfilled the inclusion criteria. The pooled sensitivities for ¹⁸FDG PET/PET-CT and BS were 0.81 (95% confidence interval [CI] = 0.70 to 0.98) and 0.39 (95% CI = 0.26 to 0.54), specificities were 0.99 (95% CI = 0.98 to 0.99) and 0.98 (95% CI = 0.96 to 0.99), and the areas under curve were 0.98 (95% CI = 0.97 to 0.99) and 0.84 (95% CI = 0.81 to 0.87).

Materials and Methods: Several databases were searched for all available articles. We calculated the sensitivities, specificities, diagnostic odds ratios, likelihood ratios, and area under summary receiver operating characteristic curves for ¹⁸FDG PET/PET-CT and BS, respectively.

Conclusions: ¹⁸FDG PET/PET-CT is superior to BS for diagnosing bone metastases in nasopharyngeal cancer patients.¹⁸FDG PET/PET-CT may enhance the diagnosis of bone metastases and provide more accurate information for the optimal management of nasopharyngeal cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20026

Publication Alerts

Meta-Analysis:

Comparison of 18FDG PET/PET-CT and bone scintigraphy for detecting bone metastases in patients with nasopharyngeal cancer: a meta-analysis

Abstract

Comparison of ¹⁸FDG PET/PET-CT and bone scintigraphy for detecting bone metastases in patients with nasopharyngeal cancer: a meta-analysis